Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Svenska Aerogel expands its presence in the Spanish, Portuguese, and Moroccan paint markets with Comindex as new distributor

Specialty chemicals company Comindex has been appointed Svenska Aerogel’s new distributor in Spain, Portugal, and Morocco. Svenska Aerogel and Comindex signed a letter of intent in 2021, but now the collaboration has been formalized with a distributor agreement. This new agreement will boost Svenska Aerogel's presence in these markets, focusing on thermal insulation paints and plasters. In countries where high temperatures are common, there is a strong demand for efficient heat insulation and reflective solutions. Svenska Aerogel believes that Quartzene[®]-infused products will play a

Report on managers' receipt of restricted shares - vesting - in Dampskibsselskabet NORDEN A/S

ANNOUNCEMENT NO. 33 - 13 FEBRUARY 2024   Under Article 19 of the Market Abuse Regulation Dampskibsselskabet NORDEN A/S is required to report transactions in Dampskibsselskabet NORDEN A/S’ shares by persons discharging managerial responsibilities and their close relatives.   With reference to announcement no. 38/2021 the following restricted shares have vested: Name:   Jan RindboReason:   Reporting duty, CEOIssuer:   Dampskibsselskabet NORDEN A/SISIN code:   DK0010269844Instrument:

Mandatum plc’s financial statement release 1 January–31 December 2023: Significant increase in profit before taxes for the IPO year 2023

Mandatum plc, Stock exchange release, 13 February 2024 at 10:45 EET October–December 2023 in brief · Profit before taxes was EUR 46.3 million (10–12/2022: 62.6). The decrease was due to a weaker net finance result weighed down by higher finance costs on with-profit insurance contract liabilities as a result of the decrease in the discount rate. · The fee result was EUR 13.4 million (6.2). · Net flow was EUR 209.9 million (199.0). · The net finance result was EUR 24.9 million (78.1). · The result related to risk policies was EUR 8.0 million (5.2). January–December 2023

Tillväxtbolaget enables investments and ownership transitions worth billions for the Swedish agriculture

Given the challenges of recent years, the conditions for investments in agricultural companies have become significantly more difficult. But Tillväxtbolaget, in which Lantmännen is a part-owner, is now presenting figures for 2023 that show a brighter picture – through Tillväxtbolaget's top loans, 82 agricultural companies have been granted investments of SEK 2.2 billion and the age of the recipients breaks the general trend.Volatile prices for input goods, rising interest rates for companies with a lot of tied-up capital, component shortages and last year, unfavorable weather with a weak

Winner of three sustainability awards at the 2024 African Mining Indaba

Media Release  13 February 2024   Base Resources LimitedWinner of three sustainability awards at the 2024 African Mining Indaba   African mineral sands producer, Base Resources Limited (ASX & AIM: BSE) (Base Resources) is pleased to announce it received three Responsible Resourcing Awards at the 2024 African Mining Indaba, improving on the two awards received at last year’s event.  The Responsible Resourcing Awards recognise and celebrate those junior miners that are redefining the narrative of responsible mining, protecting the environment, supporting local community, and

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 32 - 13 FEBUARY 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 30/24 and 31/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications & Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Inför Kebnis bokslutskommuniké 2023: Ställ din fråga till VD Torbjörn Saxmo

Kebni AB publicerar sin bokslutskommuniké 2023 på fredag den 16 februari 2024. En inspelad rapportpresentation och Q&A med Kebnis VD Torbjörn Saxmo kommer att publiceras samma dag i Kebnis digitala kanaler samt på Youtube-kanalen Penser Play .Mejla in din fråga:Det finns nu möjlighet att skicka in frågor till Q&A-segmentet. Mejla din fråga till maya.larsson@kebni.com senast 10.00 den 16:e februari. Skriv ”Q&A” i ämnesraden. Välkommen med din fråga!  Om KebniKebni har en lång historia och stor erfarenhet inom Inertial

DOF Group ASA - Contract Award and Contract Extension in APAC

DOF is pleased to announce a contract award and a contract extension securing further backlog for the APAC region. The latest contract secured for the region will utilise Skandi Hercules and see the vessel fully utilised off the Australian coast into Q3 2024. The contracted scope includes project management and engineering, logistics support and execution of various inspection, maintenance, and repair (IMR) activities.  In addition, a contract extension has been secured for Skandi Singapore with the vessel fully committed through Q3 2024 with further options available into Q1 2025.

Helping people is her biggest driver

Managing a region including 33 countries with a vast diversity in cultures, politics, economics and healthcare market dynamics might sound challenging. Zeynep Sanver, President Central and Eastern Europe at Getinge, addresses it with a strong belief in capable, empowered local teams and a passion for helping people. “Joining the healthcare sector was a conscious decision after I completed my master’s degree in engineering business management. I have always been thrilled to be part of an industry where the focus is on helping people overcome difficult situations,” says Zeynep

Notice of Axfood’s 2024 Annual General Meeting

Welcome to the Annual General Meeting (AGM) of Axfood AB (publ), corporate registration number 556542-0824, to be held on Wednesday, 20 March 2024 at 5:00 p.m. at Münchenbryggeriet, Torkel Knutssonsgatan 2 in Stockholm, Sweden. Registration for the AGM will open at 4:00 p.m. The Board of Directors has decided that shareholders may also exercise their voting rights at the AGM by postal voting, as stipulated in Axfood’s Articles of Association.Registration and notification Shareholders who wish to participate in the proceedings of the AGM must: · be registered as shareholders in the

STOREBRAND ASA: Recommendation of Board members for 2024-2025

Nomination committee's recommendation of Board members for the election period 2024-2025 to the Annual General Meeting The Board of Directors in Storebrand ASA consist of ten members, of which seven are shareholder elected and the other three are employee elected. In connection with the Annual General Meeting's election of the board for the election period 2024-2025, Didrik Munch, Karin Bing Orgland and Fredrik Åtting have chosen to retire from their board positions. The Nomination Committee of Storebrand ASA has unanimously decided to nominate the following as board members for the

Kemira Oyj: Shareholding of Solidium Oy in Kemira has decreased below 5.00 per cent

Kemira Oyj, Stock Exchange Release, February 13, 2024 at 09.50 am (EET)Kemira Oyj: Shareholding of Solidium Oy in Kemira has decreased below 5.00 per cent   This is a notification in accordance with Chapter 9, Section 10 of the Finnish Securities Market Act. Kemira Oyj has on February 13, 2024 received a notification of a change in shareholding in accordance with Chapter 9, Section 5 of the Securities Market Act.   According to the notification, the shareholding of Solidium Oy in Kemira Oyj decreased below 5.00% on February 13, 2024 and is 0 shares representing 0.00% of the

DNB Markets – Episurf Medical: Sales moving in the right direction

Q4 sales were in line with our forecast, but operating expenses were higher. Overall, we believe sales growth will be the most important parameter to track short- to medium-term. If growth continues to be strong in the OUS market and uptake of the patellofemoral system takes off in the US, we believe the company would enter a phase of high growth. It had cSEK58m cash at end-Q4, which should last until end-2024. We have tweaked our forecasts, but reiterate our fair value of SEK1.5–4.5.Q4 sales in line with our forecast but earnings lower. Sales were SEK3.2m (we forecast SEK3.3m) but

Crunchfish Digital Cash protector increases the security for 3rd party offline payment services

Protecting offline payment applications is hard as offline payment introduces specific risks relating to bearer instruments and double-spending. Crunchfish Digital Cash offline solution enables offline payment for 3rd party online payment services by offering a secure, isolated runtime and encrypted storage with rollback protection for all offline assets. Crunchfish announces now the Digital Cash protector as an offline payment application protection add-on for 3rd party offline payment services.   Offline payments introduce specific risks that need careful consideration. Since

Tokmanni Group’s Capital Markets Day 2024: Tokmanni continues its strong growth and updates its financial targets

Tokmanni Group Corporation        Stock exchange release        13 February 2024 at 9:30 amTokmanni expanded its operations beyond Finland in line with its strategy by buying the Swedish discount store chain Dollarstore in August 2023. Together, Tokmanni and Dollarstore form one of the leading discount retailers in the Nordic markets. Tokmanni and Dollarstore are determined to continue taking measures to promote strong growth. Tokmanni Group's long-term vision is to become the leading discount retailer in Northern Europe. Tokmanni Group’s target is to have a store network of over 360

Valmet to deliver electrostatic precipitators to Nordic Paper’s Bäckhammar mill in Sweden

Valmet Oyj’s press release February 13, 2024 at 9:30 a.m. EETValmet will deliver electrostatic precipitators (ESP) for the existing recovery boiler in Nordic Paper’s Bäckhammar mill in Kristinehamn, Sweden. The take over is scheduled to be in the end of 2025. The order is part of Nordic Paper’s investments to further improve the sustainability performance and the competitiveness of the company’s Bäckhammar mill, which manufactures unbleached kraft papers of different qualities, primarily for packaging purposes. Through the installation of new electrostatic precipitators, the emissions of

Stora Enso publishes its Annual Report 2023

STORA ENSO OYJ ANNUAL FINANCIAL REPORT 13 February 2024 at 9:30 EETStora Enso’s Annual Report 2023 is published today at storaenso.com/annualreport .  The report includes a strategy review, sustainability reporting, corporate governance, remuneration report and financial report.   Stora Enso publishes its annual financial statements in accordance with the European Single Electronic Format (ESEF) reporting requirements. The format of the report is Extensible Hypertext Markup Language (xHTML). In line with the ESEF requirements, the

Cline Scientific advisor discusses the future of cartilage damage treatment

A video interview featuring Professor Mats Brittberg, senior physician in orthopedics at Varberg Hospital and Professor at the University of Gothenburg talks about future treatments for cartilage damage has been published.Mats Brittberg, senior physician in orthopedics at Varberg Hospital and professor at the University of Gothenburg, is a scientific advisor to Cline Scientific. In the video published by BioStock, Brittberg discusses future treatments for cartilage damage and osteoarthritis. Brittberg highlights Cline's StemCART project and the work we are doing to develop an allogeneic

Genovis to receive USD 1 million in milestone compensation related to the development of the Xork™ enzyme

The milestone compensation is related to achieved development targets for the Xork enzyme that Genovis has out-licensed for therapeutic applications, primarily as a potential pre-treatment in gene therapy but also for autoimmune diseases.Xork is derived from a streptococcal bacterial strain that does not infect humans. The pre-clinical data generated to date highlights Xork’s differentiated profile demonstrating very low cross-reactivity with naturally occurring antibodies in human sera while retaining efficient and specific cleavage of human IgG antibodies.

Curasight resolves on a rights issue of up to DKK 51.2 million to accelerate its therapeutic strategy

Copenhagen, Denmark, 13 February 2024 - Curasight A/S ("Curasight" or the “Company" – TICKER: CURAS) has today resolved on a new issue of shares with preferential rights for the Company's existing shareholders of up to DKK 51.2 million before transaction costs (the “Rights Issue"). The proceeds are intended to be used to strengthen the Company’s capital structure and secure funding for the acceleration of clinical activities, including the preparation, planning and enrolment of the first patients in a therapy phase I/IIa basket trial in various cancer types, as well as to strengthen Curasight’

Elicera Therapeutics AB (publ) Year-End Report 1 January – 31 December 2023

Fourth quarter (October-December 2023) · Operating profit/loss amounted to SEK -5,212,694 (-3,951,799). · Loss for the period amounted to SEK -4,749,222 (-3,898,340). · Cash flow from operating activities totaled SEK 3,503,148 (5,516,307). · Earnings per share before dilution totaled SEK -0.24 (-0.20). Earnings per share after dilution totaled SEK -0.24 (-0.20). · Proposed dividend of SEK 0.00 per share (0.00 for the preceding year).   Period (January-December 2023) · Operating profit/loss amounted to SEK -17,096,277 (-19,362,750). · Loss for the period

Curasight announces acceleration of therapeutic strategy to strengthen position as a radiopharmaceutical theranostic company

· Coming Phase I/IIa basket trial planned to include five select cancer indications · Study will apply Curasight’s uPAR theranostic platform approach combining diagnosis (uTRACE[®]) and therapy (uTREAT[®]) · First patients expected to be dosed in the beginning of 2025 with expected first efficacy data in 2025. Copenhagen, Denmark, 13 February 2024 - Curasight A/S ("Curasight" or the “Company" – TICKER: CURAS) announces today that it is accelerating and expanding its clinical therapeutic strategy with the addition of a new Phase I/IIa trial to include a total of five cancer

Amuse Presents Direct Integration with YouTube for Official Artist Channels

Managing music and artist content across YouTube can be challenging and tedious. To help DIY and independent artists gain control of their presence on the platform, global music company and distributor Amuse presents an automated integration with YouTube for Official Artist Channel (OAC) access. Eligible Amuse distribution users can now request their OAC with just a few clicks, merging all subscribers and content from different parts of YouTube into one convenient channel.The integration is the latest result of Amuse’s continued ambition to solve pain points for the DIY and independent

There are no items matching the current filter
There are no more items matching the current filter
Back to top